![New FDA Bill Bypasses LDTs Reform—Again](https://www.g2intelligence.com/wp-content/uploads/2022/09/Sept24-2022.NewsVALIDAct-iStock-1800x1250-1-1080x675.jpg)
New FDA Bill Bypasses LDTs Reform—Again
It now appears that Congress is going to dash the lab industry’s hopes yet again by reauthorizing FDA user fees without VALID.
It now appears that Congress is going to dash the lab industry’s hopes yet again by reauthorizing FDA user fees without VALID.
According to healthcare groups, the Improving Seniors’ Timely Access to Care Act would help fix problems with current system.
This digital event will help labs meet the various legal, compliance, business, and technology challenges of the industry, today and tomorrow.
It remains far from clear whether the new surprise billing rule goes far enough to fix the problem of insurers having too much power in disputes.
Revised final rule essentially disarms the threat of insurers having the advantage in out-of-network price disputes.